Annovis Bio Inc. (ANVS) option IV into data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts ANVS Hot Sheet
Join SI Premium – FREE
Annovis Bio Inc. (NYSE: ANVS) 30-day option implied volatility is at 333; compared to its 52-week range of 21 to 333 into topline efficacy data for phase II/III study of buntanetap in patients with mild to moderate Alzheimer's disease is expected in April.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM (IBM) call put ratio 1.2 calls to 1 put into quarter results
- Western Digital (WDC) call put ratio 1.3 calls to 1 put as share price down 3.6%
- IREN Limited (IREN) call put ratio 1.2 calls to 1 put amid wide price movement
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
